an absolute tour-de-force review on the potential role of statins in the management of MPNs! ashpublications.org/bloodadvance...

More data to tease out the impact of TP53 on chronic-phase MPNs! www.nature.com/articles/s41...

great review on everything CALRm directed in MPNs! ashpublications.org/bloodneoplas...

helpful study focused on the development of a prognostic score for CML blast phase! Factors are: -blast percentage, platelet count, age (all at onset of CML-BP), -immunophenotype -extramedullary disease -previous history of CML www.nature.com/articles/s41...

useful real-world study supporting the addition of midostaurin to intensive chemo in adults ≥60 with FLT3m AML pubmed.ncbi.nlm.nih.gov/41671383/

This is straight-up Nazi rhetoric from Musk, and the only tiny thing I can do is address myself to those of you who are still on X. No more excuses about how you need "reach" or how good the conversation is there or the importance of debate. You will not regret walking away, and it's time.

new publication in @ascocancer.bsky.social JCO detailing the PVEK experience in BPDCN! ascopubs.org/doi/full/10....

excellent paper in @bloodjournal.bsky.social on how prior non-response to blinatumomab is associated with poor outcomes in pts with ALL that subsequently received Brexu-cel ashpublications.org/blood/articl...

There is literally no better example of textbook fascistic thinking than "Who cares about human rights when the rich are doing so very well"

Enjoyed this viewpoint on the murky line between high-risk MDS and AML! www.thelancet.com/journals/lan...

very helpful @bloodjournals.hematology.org article on use of ropeginterferon alfa-2b in pregnant patients with MPNs ashpublications.org/bloodadvance...

glad to be a part of this effort led by @michaeldrazer.bsky.social characterizing hematologic complications in patients treated with PARPi -17 of 265 pts treated with PARPi underwent BM Bx for workup of abnormal blood counts -8 of 17 diagnosed with t-MN pubmed.ncbi.nlm.nih.gov/41609051/

It's a good day to call your Senators and tell them that you are watching and that you will not forget what they do, or fail to do.

enjoyed this @bloodjournal.bsky.social article on the next wave of JAK inhibitors in development for MPNs! ashpublications.org/blood/articl...

By who? Who shot the person dead? You saw the video. We all know a federal agent shot a man dead who was prone on the ground. Also, it's not "according to officials." It's according to verified video seen with your eyes. Not saying what anyone can obviously see with their eyes is a form of lying.

check out our work now in the latest issue of BJH! We report on the efficacy of therapies in patients with acute leukemia previously treated with revumenib onlinelibrary.wiley.com/doi/10.1111/...

Phase III study of intensive chemo +/- dasatinib in CBF AML is out in @bloodjournal.bsky.social - no EFS benefit seen in the investigational arm! www.sciencedirect.com/science/arti...

ICE keeps saying the people protesting it are being paid without any evidence, but we have receipts showing that the people *defending* ICE are absolutely being paid. And yet we only hear lies about the former on cable news.

new paper led by Dr Irum Khan looking at clinical and sociodemographic contributors to ICU admission in patients with AML getting intensive chemo! Grateful to be a part of this Chicagoland collaboration haematologica.org/article/view...

check out this paper in @bloodjournals.hematology.org led by @talhabadarmd.bsky.social on PPM1D in CHIP/CCUS! Glad to contribute to this effort pubmed.ncbi.nlm.nih.gov/41499760/

glad to contribute to this effort in @bloodjournals.hematology.org looking at statin use and impact on CV outcomes in patients with MPNs! ashpublications.org/bloodadvance...

It appears ICE murdered someone in cold blood today and their plan is — per usual — to create a fog of lies so the killer does not face justice. We simply can't let that happen. The shooter has to be arrested and so does Bovino. They can't just kill people on the street.

Check out our state of the art review covering MPN-unclassifiable! pubmed.ncbi.nlm.nih.gov/41496466/

really enjoyed this article on thrombosis risk in MPNs with the incorporation of thromboinflammation markers as potential biomarkers www.nature.com/articles/s41...

interesting article in @bloodjournal.bsky.social on CD38 and fibrosis in MPNs ashpublications.org/blood/articl...

enjoyed reading this article in Haematologica regarding JAK inhibitor selection in myelofibrosis! haematologica.org/article/view...

check out this effort led by our hematopathology group to characterize the impact of chromosome 5 aberrations in TP53m myeloid malignancies with ≥5% blasts! acsjournals.onlinelibrary.wiley.com/doi/10.1002/...

Terrific to have our paper, led by @tjflemin.bsky.social, featured as a plenary article in @bloodjournal.bsky.social today: ashpublications.org/blood/articl...

thanks to @ascopost.bsky.social for letting me break down the results of our Phase II study of TKI + inotuzumab in pts with newly-dx Ph+ ALL! ascopost.com/videos/ash-2...

updated recs on MRD in AML! ashpublications.org/blood/articl...

a very useful review by @akritigjain.bsky.social et al on frontline TKI approaches in CML! haematologica.org/article/view...

interesting paper on outcomes of patients with MPAL from the MD Anderson group! ascopubs.org/doi/10.1200/...

More data on outcomes post menin inhibitor in acute leukemia are out today in @bloodjournals.hematology.org - bit.ly/4rNIS1t Our group published on this previously as well! pubmed.ncbi.nlm.nih.gov/41139955/ Re-treatment w/ ven-based treatment after menin inhibitor seems to have some response

Dr Vannucchi on a prospective study of decitabine-ven in MPN-BP #ASH25

Dr Gupta presenting on INCA033989 in ET #ASH25

Nicholas Short of @mdanderson.bsky.social presents paired analysis of NGS for IgH/TCR and PCR for BCR::ABL1 in 80 adults w/ Ph+ ALL w/ clonoSEQ MRD neg. Strong correlation between FISH+ in segmented nuclei at dx and PCR+/NGS- state later. NGS-/PCR- vs NGS-/PCR+ w/ similar OS/relapse. (1/2) #ASH25

Interesting 96w follow-up from MANIFEST-2 presented by Dr Rampal #ASH25

Come see our trial in progress poster on ivosidenib plus ruxolitinib in IDH1-mutated advanced MPNs #ASH25

Great work by Rafa Madero-Marroquin looking at CNS relapse in Ph+ ALL #ASH25

Come check out our poster for an ongoing trial of ASTX727 +/- Iadademstat in accelerated/blast-phase MPNs #ASH25

and now the plenary #ASH25 presentation from Dr Fathi of the PARADIGM study in AML!

a beautiful plenary introduction from Andrew Wei about the PARADIGM study in AML #ash25

Wow!! 🔥🔥 CDK4/6 inhibition prevents selection of #ClonalHematopoiesis with DNA-damage repair mutations after chemotherapy! Awesome presentation from Irenaeus Chan from @kellybolton.bsky.social lab! #ASH25

Catching up on posting about the rest of the ALL abstracts! #ASH25 Dr Chiaretti on the phase 3 GIMEMA ALL2820 study

Got to present our Ph+ ALL TKI plus inotuzumab study at #ASH25! Highlights: -all patients achieved MR4 or NGS negativity -VOD seen with initial schema, updated schema splitting InO and TKI had no VOD -80% OS and 76% EFS with no CNS relapse, one systemic relapse, and no allo-HCT

Getting ready to present our Ph+ ALL data at the morning oral session! #ASH25

Congrats to @andrewthepalmer.bsky.social on his excellent poster on air pollutant exposures in myelofibrosis! #ASH25

Next MPN oral session! #ASH25 Dr Yu presenting on TKI resistance in CML via endothelial progenitor cells

At the #ash25 MPN basic/translational session! First up Dr Crispino on menin inhibition in MPNs

Love to see @andrewthepalmer.bsky.social and Sam Yates recognizing for their excellent abstracts at #ASH25 - learn more about them below! ashpublications.org/blood/articl... ashpublications.org/blood/articl...